- Home
- SHOT vs LTRN Comparison
SHOT vs LTRN Comparison
Compare SHOT & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOT
- LTRN
- Stock Information
- Founded
- SHOT 2018
- LTRN 2013
- Country
- SHOT United States
- LTRN United States
- Employees
- SHOT N/A
- LTRN N/A
- Industry
- SHOT Biotechnology: Pharmaceutical Preparations
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- SHOT Health Care
- LTRN Health Care
- Exchange
- SHOT Nasdaq
- LTRN Nasdaq
- Market Cap
- SHOT 31.4M
- LTRN 33.7M
- IPO Year
- SHOT 2020
- LTRN 2020
- Fundamental
- Price
- SHOT $0.48
- LTRN $4.83
- Analyst Decision
- SHOT
- LTRN Hold
- Analyst Count
- SHOT 0
- LTRN 1
- Target Price
- SHOT N/A
- LTRN N/A
- AVG Volume (30 Days)
- SHOT 673.2K
- LTRN 165.9K
- Earning Date
- SHOT 03-31-2025
- LTRN 03-17-2025
- Dividend Yield
- SHOT N/A
- LTRN N/A
- EPS Growth
- SHOT N/A
- LTRN N/A
- EPS
- SHOT N/A
- LTRN N/A
- Revenue
- SHOT $652,495.00
- LTRN N/A
- Revenue This Year
- SHOT N/A
- LTRN N/A
- Revenue Next Year
- SHOT N/A
- LTRN N/A
- P/E Ratio
- SHOT N/A
- LTRN N/A
- Revenue Growth
- SHOT 68.01
- LTRN N/A
- 52 Week Low
- SHOT $0.45
- LTRN $2.79
- 52 Week High
- SHOT $2.91
- LTRN $11.99
- Technical
- Relative Strength Index (RSI)
- SHOT 38.76
- LTRN 55.72
- Support Level
- SHOT $0.46
- LTRN $4.60
- Resistance Level
- SHOT $0.48
- LTRN $5.70
- Average True Range (ATR)
- SHOT 0.05
- LTRN 0.53
- MACD
- SHOT 0.01
- LTRN -0.03
- Stochastic Oscillator
- SHOT 18.74
- LTRN 43.87
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.